PML is induced by oncogenic ras and promotes premature senescence

Genes and Development

Volumn 14, Issue 16, 2000, Pages 2015-2027

  Ferbeyre, Gerardo ^a   De Stanchina, Elisa ^a   Querido, Emmanuelle ^a   Baptiste, Nicole ^b   Prives, Carol ^b   Lowe, Scott W ^a  

^a Simons Center for Quantitative Biology   (United States)

^b Columbia University ^*  (United States)

Author keywords

P16; P53; PML; Ras; Retinoblastoma protein; Senescence

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL AGING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

CELL AGING; GENES, RAS; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 0034663873     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
2. A critical role for telomeres in suppressing and facilitating carcinogenesis
3. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha
4. The biology of replicative senescence
5. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents
6. Effects of p21 Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases
7. E1A signaling to p53 involves the p19(ARF) tumor suppressor
8. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
9. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
10. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor
11. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling
12. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2
13. A novel macromolecular structure is a target of the promyelocyte- retinoic acid receptor oncoprotein
14. The regulation of E2F by pRB-family proteins
15. Induction of apoptosis in fibroblasts by c-myc protein
16. The complexity of p53 modulation: Emerging patterns from divergent signals
17. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia
18. Overexpression of plasminogen activator inhibitor typed in senescent fibroblasts from normal subjects and those with Werner syndrome
19. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis
20. Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene
21. Creation of human tumour cells with defined genetic elements
22. The limited in vitro lifetime of human diploid cell strains
23. Altered distribution of the promyelocytic leukemia-associated protein is associated with cellular senescence
24. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML
25. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p 19ARF
26. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins
27. Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment
28. Expression of interleukin-1 alpha and beta in early passage fibroblasts from aging individuals
29. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs
30. Phosphorylation of p53 serine 15 increases interaction with CBP
31. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body
32. The acute promyelocytic leukaemia-associated PML gene is induced by interferon
33. Binding and modulation of p53 by p300/ CBP coactivators
34. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling
35. p53 Mediates permanent arrest over multiple cell cycles in response to gamma-irradiation
36. p53-Dependent apoptosis modulates the cytotoxicity of anti-cancer agents
37. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b)
38. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts
39. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis
40. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
41. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts
42. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase
43. PML, a growth suppressor disrupted in acute promyelocytic leukemia
44. Differential growth state-dependent regulation of plasminogen activator inhibitor type-1 expression in senescent IMR-90 human diploid fibroblasts
45. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
46. Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53
47. p19ARF links the turnout suppressor p53 to Ras
48. Signaling to p53: Breaking the MDM2-p53 circuit
49. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins
50. The tumor suppressor protein p16INK4a
51. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
52. Microarray analysis of replicative senescence
53. The ARF/p53 pathway
54. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
55. DNA damage induces phosphorylation of the amino terminus of p53
56. The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression
57. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element
58. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
59. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
60. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1
61. Induction of senescence in human malignant glioma cells by p16INK4a
62. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase
63. Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts
64. Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs
65. Role of PML in cell growth and the retinoic acid pathway
66. Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage
67. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells
68. Association between an oncogene and an anti-oncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product
69. One-day northern blotting for detection of mRNA: NDGA inhibits the induction of MnSOD mRNA by agonists of type 1 TNF receptor
70. LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression
71. The transcriptional role of PML and the nuclear body
72. Senescence of human fibroblasts induced by oncogenic Raf